- No impact at this time on the listing of the Company's Ordinary Shares on Nasdaq
- Company intends to submit to Nasdaq a compliance plan
Portage Biotech Receives Nasdaq Noncompliance Letter
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.